Publication | Closed Access

Pregnancy exposure to venlafaxine—Therapeutic drug monitoring in maternal blood, amniotic fluid and umbilical cord blood and obstetrical outcomes

Amniotic FluidMaternal Cardiovascular OutcomeMedicineGynecologyPregnancyMaternal HealthObstetricsVenlafaxine—therapeutic Drug MonitoringMaternal-fetal MedicinePublic HealthPharmacologyHigh-risk PregnancyPregnancy Exposure